Search
The presence of Pseudomonas aeruginosa biofilms in lower airway specimens from cystic fibrosis (CF) patients is well established.
Stratification of monitoring protocols based on the risk profile of the patient can help us in the future to better care for people with Cystic Fibrosis.
This paper is a review of lung function tests best suited to use for early detection of lung disease in Cystic Fibrosis.
Understanding early triggers of Cystic Fibrosis Lung Disease
Wall teichoic acid may be important for protecting S. aureus against exposure to bile
This study aimed to determine how pulmonary inflammation & infection impacts on ventilation distribution throughout early life in people with cystic fibrosis.
Cystic fibrosis related progressive lung disease characterised by inflammation and infection commences soon after birth.
Researchers are able to track the progress of lung disease through a comprehensive longitudinal set of biological samples, images and data archives.
Children with cystic fibrosis will be included in the next phase of a clinical trial of a promising new treatment pioneered in Western Australia aimed at boosting their immune responses to infections. Originally developed by researchers at The Kids Research Institute Australia and Perth Children’s Hospital.
Newborn screening (NBS) for cystic fibrosis (CF) provides an opportunity to commence management and therapeutic interventions significantly earlier